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Abstract: Dichloromethane (methylene chloride) is a widely used chlorinated solvent. We 
review the  available epidemiology studies (five cohort studies, 13 case-control studies, 
including seven of hematopoietic cancers), focusing on specific cancer sites. There was 
little indication of an increased  risk of lung cancer in the  cohort studies (standardized 
mortality ratios ranging from 0.46 to 1.21). These cohorts are relatively small, and variable 
effects  (e.g.,  point  estimates  ranging  from  0.5  to  2.0)  were  seen  for  the  rarer  forms  
of  cancers  such  as  brain  cancer  and  specific  hematopoietic  cancers.  Three  large  
population-based case-control studies of incident non-Hodgkin lymphoma in Europe and 
the United States observed odds ratios between 1.5 and 2.2 with dichloromethane exposure 
(ever exposed or highest category of exposure), with higher risk seen in specific subsets of 
disease. More limited indications of associations with brain cancer, breast cancer, and liver 
and biliary cancer were also seen in this collection of studies. Existing cohort studies, 
given their size and uneven exposure information, are unlikely to resolve questions of 
cancer  risks  and  dichloromethane  exposure.  More  promising  approaches  are  
population-based  case-control  studies  of  incident  disease,  and  the  combination  of  data  
from  such  studies,  with  robust  exposure  assessments  that  include  detailed  
occupational  information  and  exposure  assignment  based  on  industry-wide  surveys  or 
direct exposure measurements.  
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1. Introduction 
Dichloromethane  (methylene  chloride)  has  been  used  extensively  as  a  paint  stripper  and  metal 
degreaser and as an extraction solvent in the food industry (e.g., in decaffeination of coffee), in the 
pharmaceutical industry, and in the production of cellulose triacetate film and fiber. Production and 
use in the United States peaked around 1980, with a production capacity of 830 million pounds per 
year [1], decreasing more recently to 350 to 650 million pounds per year [2]. 
Concerns relating to the carcinogenic potential of dichloromethane arose in the 1980s, based in 
large  part  on  results  from  a  2-year  inhalation  exposure  experiment  conducted  by  the  National 
Toxicology Program (NTP), in which dichloromethane exposure resulted in an increased incidence of 
liver  and  lung  tumors  in  male  and  female  B6C3F1  mice  [3,4].  Metabolism  of  dichloromethane  is 
hypothesized to involve two primary pathways: a CYP2E1 dependent oxidative pathway producing 
carbon monoxide, and a glutathione-S transferase-theta 1 (GST-T1)-catalyzed pathway resulting in the 
production of two highly reactive intermediates, formaldehyde and S-(chloromethyl)glutathione, and 
carbon dioxide [5-7]. The proportion of dichloromethane metabolized via the GST pathway increases 
at higher exposures. Although GST is considered a detoxification pathway for many chemicals, in the 
case of dichloromethane it is the GST pathway that has been most strongly implicated in genotoxicity 
and carcinogenicity [8-15]. 
The  database  of  epidemiology  studies  focusing  specifically  on  dichloromethane  has  expanded 
considerably  with  the  addition  of  recent  studies  of  hematopoietic  cancers  conducted  in  
Europe  [16-18]  and  North  America  [19-22].  The  purpose  of  this  paper  is  to  review  the  currently 
available  epidemiology  studies, focusing on specific cancer sites reported in rodent bioassays  and 
identified through a review of the dichloromethane literature, and highlighting issues that could be 
addressed in future research. 
2. Methods 
We searched the MEDLINE database (last accessed on 30 March 2011) for epidemiologic studies 
related to dichloromethane and cancer risk, using dichloromethane, methylene chloride, cohort and 
case-control as search terms. References within relevant reports were also reviewed, and through this 
process  we  identified  three  papers  [16,17,20]  that  were  not  found  through  the  MEDLINE  search 
strategy because dichloromethane was not used as an indexing term (i.e., the abstract and key words 
did not include dichloromethane, but dichloromethane-specific data were presented in the analysis). 
We  supplemented  this  search  with  a  review  of  cancer  epidemiology  studies  with  data  on 
trichloroethylene and tetrachloroethylene, two related solvents with extensive epidemiology databases, 
to  identify  any  other  papers  evaluating  cancer  risk  from  dichloromethane  exposure  that  had  
been missed. 
Eighteen papers based on epidemiologic studies of cancer risk were identified and included in this 
evaluation: four cohorts for which the primary solvent exposure was to dichloromethane, one large Int. J. Environ. Res. Public Health 2011, 8                 
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cohort  of  civilian  employees  at  a  military  base  with  exposures  to  a  variety  of  solvents,  and  13  
case-control studies of specific cancers with data on dichloromethane exposure. Publications based on 
shorter follow-up periods of some of the cohort studies were also identified and reviewed [23-28]. 
Because our focus was dichloromethane-specific results, we did not include studies that only provided 
estimates of general categories of solvents (e.g., any solvent, or chlorinated solvents). 
3. Results 
3.1. Cohort Studies 
No cohort studies examining cancer incidence and dichloromethane exposure were identified in the 
literature search; cohort mortality studies with cancer data are summarized in Table 1. Two cohorts 
were conducted among cellulose triacetate film manufacturing workers in New York State and the 
United Kingdom, with approximately 1,000 to 1,500 male workers and mean exposure concentrations 
of  20  to  40  ppm  [29,30].  Two  other  cohort  studies  were  conducted  among  workers  in  cellulose 
triacetate fiber plants in South Carolina and Maryland [28,31,32]. The two fiber plant studies involved 
higher dichloromethane exposure, and the study in Maryland [32] contained twice as many workers 
but a shorter mean follow-up period, compared with the two studies of film manufacturing workers. In 
each of these four studies, the relatively small number of deaths greatly limits their ability to provide 
insights regarding site-specific cancers other than lung.  
Overall, there is little indication of an increased risk of lung cancer among these studies, with 
estimated SMRs generally <1.0 (ranging from 0.46 to 1.21). One study included discussion of smoking 
history, obtained from a survey at the facility, that indicated that smoking rates were similar in the 
workers compared with the general population; thus it is unlikely that differences in smoking could be 
masking an effect of dichloromethane [29]. Only one of the cohort studies reported an increased risk of 
liver or biliary tract cancer. In the latest follow-up of the South Carolina fiber plant cohort, the SMR 
for liver and bile duct cancer, based on four observed cases, was 2.98 (95% CI 0.81–7.63), lower than 
the SMR of 5.75 (95% CI 1.82–13.8) that was reported in the 1990 analysis based on these same four 
cases but on a shorter follow-up period (and thus lower number of expected cases) [28,31]. Three of 
these cases were biliary tract cancers. Elevated SMRs (point estimates greater than 1.0) were seen for 
brain cancer in both film production cohorts: SMR = 2.16 in New York [29] and 1.45 in the United 
Kingdom [30], with more mixed results seen in the fiber production cohorts. These estimates are based 
on a small number of observations (ranging from 1 to 6) and so are relatively imprecise. Although 
estimates of associations for leukemia (ICD-9 codes 204, 208) were available for all of the film and 
fiber cohort studies, only one study [29] provided data for non-Hodgkin lymphoma (ICD-9 code 200, 
202; SMR 0.49, 95% CI 0.06–1.76, based on two observed cases). The results for leukemia were based 
on between 0 and 8 observed cases, with one SMR suggesting a doubling of risk (SMR 2.04, 95% CI 
0.88–4.03) [29], and the other estimates approximately equal to or less than 1.0. None of the studies 
provided data on leukemia subtype.  
Radican et al. is the latest follow-up of a large cohort study of 14,000 civilian workers, 1,222 of 
whom were exposed to dichloromethane, employed at Hill Air Force Base in Utah for at least 1 year 
from  1952  to  1956,  with  follow-up  through  2000  [26,27,33,34].  The  most  detailed  exposure Int. J. Environ. Res. Public Health 2011, 8                 
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assessment was done for trichloroethylene, the primary focus of the study. Dichloromethane, one of 25 
other exposures analyzed, was classified as a dichotomous exposure (ever exposed, never exposed), 
and dichloromethane associations were reported for only three cancer sites (non-Hodgkin lymphoma, 
multiple myeloma and female breast cancer) [33]. The rate ratios for non-Hodgkin lymphoma and 
multiple  myeloma  in  relation  to  dichloromethane  in  men  were  2.2  (95%  CI  0.76–5.42)  and  2.58 
(95% CI 0.86–7.72), respectively. These rate ratios (particularly those for multiple myeloma) were 
higher than those for any of the other chemicals examined; the next highest observed rate ratios for 
multiple  myeloma  were  2.1,  2.0,  and  2.0  for  o-dichlorobenzene,  Freon,  and  the  “other  alcohols” 
category,  respectively.  No  cases  of  either  of  these  cancers  were  observed  in  women  with 
dichloromethane exposure, but the rate ratio for breast cancer in women was 2.35 (95% CI 0.98–5.65). 
Associations of similar magnitude or higher (rate ratios of 2.3–2.8) were also seen between breast 
cancer and some other exposures (Freon, solder flux, isopropyl alcohol, and 1,1,1-trichloroethane). All 
of these risk estimates were slightly attenuated from the estimates in the earlier examination of this 
cohort (with follow-up to 1990) described by Blair et al. [27].  
The cohort studies with the strongest design are the two triacetate film base production cohorts 
(Cohort 1 in New York and the United Kingdom cohort, reported in [29] and [30], respectively. These 
are the cohorts with the most extensive exposure assessment information, and that considered exposure 
level and duration (as summarized by cumulative exposure) in the analysis. The start of eligibility for 
cohort entrance corresponds with the beginning of the time when the exposure potential at the work 
site began, and the follow-up period is relatively long (mean >25 years). Hearne and Pifer [29] also 
included an analysis of a “Cohort 2”, based on 1,013 men employed at least one year between 1964 
and  1970.  There  is  some  overlap  between  Cohort 1  and  Cohort  2;  707  men  were  included  in  
both  cohorts.  Cohort  2  was  the  focus  of  previous  analyses  by  Friedlander  et  al.  [23]  and  
Hearne et al. [24,25]. It is not an inception cohort, and would have missed anyone leaving, possibly 
because of illness or death, before 1964).   
Although the exposure levels in the cohorts involved in cellulose triacetate fiber production were 
higher than those of the film production cohorts, the duration of exposure was relatively short in the 
South Carolina cohort (56% < 5 years) [31]. In addition, detailed work history information was only 
available for 475 (37%) of the workers [28], and it is not clear how the exposure assessment was 
applied to workers with missing job history data. In the Maryland triacetate fiber production plant, 
duration of exposure was not reported [32], and was not considered in the analysis. Also, the cohort 
began in 1970, even though production began in 1955, and the missing personnel records made it 
impossible to recreate an inception cohort. The exposure assessment in the study of civilian Air Force 
base  workers  [33]  allowed  for  only  a  dichotomized  classification  of  dichloromethane  and  other 
solvents (with the exception of trichloroethylene). For the breast cancer results, the magnitude of the 
risk estimates for some of the other solvents (i.e., associations similar to or stronger than that seen with 
dichloromethane) makes it difficult to determine from the available data how much of the increased 
risk seen with dichloromethane could be accounted for by potential confounding. The use of mortality 
rather than incidence data, which is of particular concern for cancers with a relatively good survival 
rate, such as non-Hodgkin lymphoma, is another limitation of all of these cohort studies.  Int. J. Environ. Res. Public Health 2011, 8                 
 
3384
Table 1. Summary of cohort studies of cancer risk and dichloromethane exposure. 
First author [reference], 
location  
Total n, exposure level (8 hour 
TWA) 
a, follow-up period 
Inclusion criteria, 
referent group(s) 
Exposure assessment; 
outcome assessment 
Results 
Hearne [29] 
Cellulose triacetate film 
base production; 
New York (“Cohort 1”) 
n = 1,311 men; Mean 39 ppm; 
mean duration, 17 years;  
follow-up through 1994; mean  
follow-up, 35 years 
Began working after 
1945; worked at least 
1 year; referent = New 
York State excluding 
New York City 
Work history (job records) and 
personal/air monitoring; 
cumulative exposure based on 
summation across jobs of 
duration and average exposure. 
Death certificate (underlying 
causes)  
SMR (95% CI) (n observed cases): 
  lung cancer 0.75 (0.49–1.09) (27) 
  liver cancer 0.42 (0.01–2.36) (1) 
  brain cancer 2.16 (0.79–4.69) (6)  
  leukemia 2.04 (0.88–4.03) (8) 
  pancreatic 0.92 (0.30–2.14) (5) 
  non-Hodgkin 0.49 (0.06–1.76) (2) 
  multiple myeloma 0.68 (0.01–3.79) (1) 
Tomenson [30] 
Cellulose triacetate film 
base production; 
United Kingdom 
 
n = 1,473 men; mean 19 ppm; 
mean duration, 9 years;  
follow-up through 1994; mean 
follow-up, 27 years 
Employed anytime 
between 1946 and 
1988; referent = 
England and Wales 
Work history (job records) and 
personal/air monitoring (30% 
missing details of work 
history); cumulative exposure 
based on summation across 
jobs of duration and average 
exposure. Death certificate 
(underlying causes) 
SMR (95% CI) (n observed cases): 
  lung cancer 0.46 (0.29–0.75) (19) 
  liver cancer 0 observed, 1.5 expected 
  brain cancer 1.45 (0.40–3.72) (4) 
  pancreatic 0.68 (0.14–1.99) (3) 
  leukemia 1.11 (0.23–1.87) (3) 
Lanes [28,31] 
Cellulose triacetate fiber 
production; South Carolina 
n = 551 men, 720 women (total 
n = 1,271); median 140, 280, 
and 475 ppm in low, moderate, 
and high groups; 56% <5 years 
work duration; follow-up 
through 1990; mean follow-up, 
~28 years 
Worked at least 3 mo 
in the preparation or 
extrusion areas from 
1954 to 1977;  
referent = York 
County, South 
Carolina 
Job history data and 
personal/air monitoring of 
specific areas (but job history 
data available for 37%); no 
analysis by variation in 
exposure. Death certificate 
(underlying and contributing 
causes) 
SMR (95% CI) (n observed cases): 
  lung cancer 0.80 (0.43–1.37) (13) 
  liver cancer 2.98 (0.81–7.63) (4) 
  brain cancer 
a 0.67 (0.2–3.71) (1) 
  pancreatic 0.83 (0.10–7.63) (2) 
  leukemia 
a 0.54 (0.11–1.57) (1) Int. J. Environ. Res. Public Health 2011, 8                 
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Table 1. Cont. 
First author [reference], 
location  
Total n, exposure level (8 hour 
TWA) 
a, follow-up period 
Inclusion criteria, 
referent group(s) 
Exposure assessment; 
outcome assessment 
Results 
Gibbs [32] 
Cellulose triacetate fiber 
production; Maryland 
n = 1,931 men and 978 women 
(total n = 2,909); 50–100 ppm in 
low and 350–700 ppm in high 
exposure; duration not reported; 
follow-up through 1989; mean 
follow-up 17 years 
 
Employed on or after 
January 1, 1970, for at 
least 3 month 
(potential exposure 
began 1955);  
referent = Allegany 
County, Maryland 
Work history (job records) and 
personal/air monitoring; 
divided into “high”  
(350 to 700 ppm) and “low” 
(50 to 100 ppm) exposure. 
c 
Death certificate (fields used 
not stated) 
SMR
b (n observed cases) in men; women: 
  lung cancer 0.66 (35); 1.21 (11) 
  liver cancer 0.78 (2); 0.0 (0) 
  brain cancer 0.52 (2); 2.74 (2) 
  pancreatic 0.58 (3); 0.52 (1) 
  leukemia
a 1.15 (5); 0.0 (0) 
  breast not reported; 0.92 (10) 
Radican [33,34], Air Force 
Base, Utah (follow-up of 
[27] and [26]) 
n = 10,461 men and 
3,605 women (total n = 14,066); 
exposure dichotomized  
(yes, no); exposure duration  
not reported; follow-up through 
2000; mean follow-up 
~29 years 
Employed at least  
1 yr from 1952 to 
1956 (potential 
exposure began 1939); 
internal referent 
(unexposed workers) 
Work history (job records) and 
industrial hygiene assessment 
based on work site review 
(dichotomized exposure);  
death certificate (underlying 
and contributing causes) 
RR (95% CI), in men: 
  non-Hodgkin’s lymphoma 
  2.02 (0.76–5.42 (8) 
  multiple myeloma 2.58 (0.86–7.76) (7) 
RR (95% CI), in women: 
  breast cancer 2.35 (0.98–5.65) (6) 
a Data included in a report by Gibbs [35] that included more extensive data for both triacetate fiber cohorts. 
b Calculated by summing observed and expected across exposure groups. 
c Exposure classification based on a specific job, rather than a summed exposure across all jobs. 
The 8-hour threshold limit value before 1975 was 500 ppm , and the current OSHA Permissible Exposure Level (PEL) is 25 ppm. 
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3.2. Case-Control Studies 
Case-control studies offer the potential for increased statistical power for assessing associations 
with  relatively  rare  cancers.  No  case-control  studies  of  liver  or  lung  cancer  and  dichloromethane 
exposure were identified in the literature search. Six recent case-control studies of dichloromethane 
exposure and hematopoietic cancers in adults are summarized in Table 2; this Table also includes one 
study of dichloromethane exposure and childhood leukemia. These are all population-based studies 
based on incident cases identified through cancer registries, with the number of cases ranging from  
180 [22] to 1,428 [17]. No association was seen in the study of adult leukemia (ICD-9 204,208) in 
Italy [16], although the results for the subtype of chronic lymphatic leukemia (ICD-9 204.1), based on 
150 cases, suggest a possible association in the higher intensity exposure category. This subset was 
also included in the analysis of non-Hodgkin lymphoma cases presented in Miligi et al. [17], grouped 
within the subtype of small-cell lymphocytic lymphoma. The three studies of non-Hodgkin lymphoma 
in Germany, Italy and Connecticut observed ORs between 1.5 and 2.2 with dichloromethane exposure 
(ever exposed, or highest category of exposure) [17-20]. In studies that reported more detailed results, 
there was also some evidence of higher risk among specific subsets of disease, including small-cell 
lymphocytic lymphoma [17] and diffuse large B-cell lymphoma [19].  
Two studies included multiple myeloma cases, but in one of these only four cases were exposed to 
dichloromethane so effect estimates were not presented [16]. In the study by Gold et al., 180 multiple 
myeloma cases were selected from two Surveillance, Epidemiology and End Results (SEER) cancer 
registries [22]. One set of analyses included any possible exposure among the exposed, and a second 
set  of  analyses  included  the  low  confidence  exposure  jobs  with  the  unexposed  group.  In  general, 
somewhat stronger associations or patterns were seen in the second analyses. The OR for ever exposed 
was 1.5 (95% CI 0.9–2.3) in the first analysis and 2.0 (95% CI 1.2–3.2) with the reclassification of the 
low confidence jobs. In the second set of analyses, a non-monotonic increasing trend was seen with 
duration of exposure (OR 1.0, 2.0, 1.1, 2.7, and 2.1, respectively, in the unexposed, 1–4, 5–7, 8–24, 
and 25–47 years duration groups, trend p = 0.01). Similar patterns were seen with cumulative exposure 
(trend p = 0.08) and cumulative exposure lagged by 10 years (trend p = 0.06).  
In the only study of childhood acute lymphoblastic leukemia, a weak association was seen between 
any maternal dichloromethane exposure during the 2 years before pregnancy up to the birth (OR 1.34 
[95% CI 0.54–3.34]); results were similar when limited to exposures during pregnancy [21]. Stronger 
associations were seen with probable or definite exposure (OR 3.22 [95% CI 0.88–11.7]) compared 
with possible or no exposure. The estimates for categories based on concentration and frequency were 
similar but there was no evidence for an increasing risk with increasing exposure level. 
Each  of  these  case-control  studies  obtained,  using  a  structured  interview  format,  detailed 
information about all jobs held (or, in the case of the study of childhood leukemia, jobs held in the two 
years before and during the pregnancy), rather than just the usual or most recent job. This information 
includes job and industry titles in addition to description of tasks and materials, and was used in 
conjunction with a job exposure matrix developed to assess intensity and probability of exposure, 
taking into account temporal changes in solvent use within specific types of workplaces. This exposure 
assessment procedure is based in large part on expert judgment, for example, by industrial hygienists 
familiar with specific types of workplaces, and is conducted blinded to case-control status. Five of the Int. J. Environ. Res. Public Health 2011, 8                 
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studies included supplemental job-specific and industry-specific questionnaire modules focusing on 
potential exposure to specific solvents [16-18,21,22]. The structured and detailed interview format 
reduces the potential for a differential reporting of exposures by study participants. The addition of 
specific  questionnaire  modules  designed  to  obtain  more  detailed  information  regarding  tasks  and 
exposure conditions also improves the reliability of the assessment. 
Case-control studies of dichloromethane exposure and other types of cancers are summarized in  
Table  3.  There  was  little  evidence  of  associations in  the  studies  of  breast  cancer  [36],  pancreatic  
cancer [37], kidney cancer [38] or rectal cancer [39]. Two case-control studies of dichloromethane 
exposure and brain cancer have been conducted [40,41]. The stronger of these studies in terms of detail 
of exposure data was the Heineman et al. study based on cases identified using death certificates from 
southern Louisiana, northern New Jersey, and the Philadelphia area, with confirmation of diagnosis 
using hospital records [41]. Controls (frequency matched to cases by age, year of death, and study 
area) were randomly selected from the death certificates of white males who died of causes other than 
brain tumors, cerebrovascular disease, epilepsy, suicide, and homicide. Data pertaining to lifetime job 
history  were  collected  from  next-of-kin  interviews  for  cases  and  controls.  There  was  a  trend  of 
increasing risk with increasing probability of exposure to dichloromethane (OR = 1.0, 95% CI 0.7–1.6, 
for low probability; OR = 1.6, 95% CI 0.8–3.0, for medium probability; OR = 2.4, 95% CI 1.0–5.9, for 
high probability compared with the referent group of unexposed men; trend p-value < 0.05).  The 
highest risk was seen with the combination of long duration (>20 years) and high intensity (or high 
probability) exposure. Similar results were seen in additional analyses controlling for age, study area, 
employment  in  electronics  occupations  and  industries,  and  exposure  to  carbon  tetrachloride, 
tetrachloroethylene, and trichloroethylene. In the analyses adjusting for these other exposures, only 
dichloromethane exhibited a trend with increasing probability of exposure.  
As with the case-control studies of hematopoietic cancers, each of these studies used a job exposure 
matrix  based  on  expert  judgment  for  the  classification  of  various  dimensions  of  exposure  (e.g., 
probability, intensity, frequency). The job exposure matrix approach is based on work in the 1990s by 
the National Cancer Institute [42,43]. There is a considerable range among these studies, however, in 
the detail and quality of the exposure information upon which the classification scheme  could be 
applied, from death certificate occupation data [36,37,40], to interview-based information on most 
recent and usual jobs [38], to a lifetime job history [39,41]. Dell et al. noted the limitation of the lack 
of direct exposure measures in this type of assessment, and the difficulty in categorizing jobs with 
occasional exposure to a specific solvent [44]. The reliability of this procedure is likely to have been 
improved in the Heineman et al. study [41] by the use of more detailed coding of specific jobs within 
the industry and occupation code categories to distinguish those of particular relevance to a specific 
exposure  (e.g.,  production  of  paint  removers  within  the  broader  category  of  production  of  paints, 
varnishes, lacquers, enamels, and allied products) [43]. Int. J. Environ. Res. Public Health 2011, 8                 
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Table 2. Summary of case-control studies of hematopoietic cancer risk and dichloromethane exposure. 
Cancer type, first author [reference], study details  Exposure assessment  Results
a 
Leukemia 
Costantini [16], Italy (7 areas) 586 incident cases, 1,278 
population-based controls (area population files);  
1991–1993; cancer classification based on NCI protocol; 
ages 20–74 years, men and women, participation rate  
85% (cases), 72% (controls) 
Job exposure matrix applied to work history (all jobs 
held at least 5 years) ascertained through interviews, 
job-specific and industry-specific questionnaires (for 
solvent-and other chemical-related jobs). Probability 
and intensity ratings; 10 specific solvents 
intensity measure—all leukemia: 
  very low/low OR 0.7 (0.3–1.7) 
  medium/high OR 0.5 (0.1–2.3) 
Chronic Lymphatic Leukemia: 
  very low/low OR 0.4 (0.1–2.0) 
  medium/high OR 1.6 (0.3–8.6) 
Non-Hodgkin lymphoma 
Miligi [17], Italy (8 areas) 1,428 incident cases, 1,530 
population-based controls (area population files);  
1991–1993; cancer classification based on NCI protocol; 
ages 20–74 years, men and women, participation rate  
83% (cases), 73% (controls) 
Job exposure matrix applied to work history (all jobs 
held at least 5 years) ascertained through interviews, 
job-specific and industry-specific questionnaires (for 
solvent-and other chemical-related jobs). Probability 
and intensity ratings; 10 specific solvents 
Intensity measure: 
  very low/low OR 0.9 (0.5–1.6) 
  medium/high OR 1.7 (0.7–4.3) 
Small Lymphocytic subtype: 
  any exposure OR 3.2 (1.0–10.1) 
Seidler [18], Germany (6 areas); 710 incident cases, 710 
population-based controls (area population files),  
1999–2003; ages 18–80 years, men and women, 
participation rate 87% (cases), 44% (controls) 
Job exposure matrix applied to work history (all jobs 
held at least 1 year) ascertained through interviews, 
job-specific and industry-specific questionnaires (for 
solvent-and other chemical-related jobs). Probability 
and intensity ratings; 8 specific solvents 
Cumulative exposure (ppm-years): 
  0 OR 1.0 (referent) 
  >0 to ≤26.3 OR 0.4 (0.7–5.2) 
  >26.3 to ≤175 OR 0.8 (0.3–1.9) 
  >175 OR 2.2 (04–11.6) 
Wang [20]; Barry [19], Connecticut, 601 incident cases, 
717 population-based controls (random digit dialing and 
Medicare files), 1996–2000; ages 21–84 years, women, 
participation rate 72% (cases), 69% (random digit dialing 
controls), 47% (Medicare controls). Barry [19] is limited 
to 518 cases and 597 controls with blood or buccal cell 
sample for genotyping 
Job exposure matrix applied to work history (all jobs 
held at least 1 year) ascertained through interviews 
(job and industry titles, duties). Probability and 
intensity ratings; 8 specific solvents 
Ever exposure: OR 1.5 (1.0–2.3) 
Little difference in risk by probability or 
intensity score. 
Diffuse Large B-cell Lymphoma: 
  OR 2.10 (1.15–3.85) 
TT genotype of CYP2E1 rs20760673: 
  OR 4.42 (2.03–9.62) Int. J. Environ. Res. Public Health 2011, 8                 
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Table 2. Cont. 
Cancer type, first author [reference], study details  Exposure assessment  Results
a 
Multiple Myeloma   
Gold [22], Seattle, Washington and Detroit, Michigan  
(2 SEER sites). 180 incident cases; 481 population-based 
controls (random digit dialing and Medicare files),  
2000–2002; ages 35–74 years, men and women, 
participation rate 50% (cases), 52% (controls) 
Job exposure matrix applied to work history (all jobs 
held since age 15) ascertained through interviews,  
job-specific questionnaires (for solvent-related jobs 
held at least 2 years). Probability, frequency , intensity 
and confidence ratings; 6 specific solvents 
Low confidence jobs as unexposed: 
Ever exposed OR 2.0 (1.2–3.2) 
Trends with duration (p = 0.01), cumulative     
exposure (p = 0.08) and 10-year lagged 
cumulative exposure (p = 0.06) 
Childhood leukemia (acute lymphoblastic leukemia) 
Infante-Rivard [21], Quebec, Canada. 790 incident cases 
(hospitals—all provinces), 790 population-based controls 
(government population registries), 1980–2000; cancer 
based on oncologist or hematologist diagnosis, ages 0–14 
years
 a, boys and girls, participation rate 93% (cases), 
86% (controls) 
Systematic review of detailed information on all jobs 
held by the mother from 2 years before pregnancy 
through birth of the child; 21 individual substances and 
six mixtures evaluated (mostly solvents); confidence, 
frequency, and concentration of exposure ratings 
Little evidence of association with any 
exposure, OR 1.34 (0.54, 3.34), but stronger 
associations with probable or definite, OR 
3.22 (0.88, 11.7) (referent group = 
possible/no exposure) and with combinations 
of frequency and concentration 
a From 1980 to 1993, study was limited to diagnoses of ages 0–9, but this was expanded between 1994 and 2000 to ages 0–14. 
 
Table 3. Summary of case-control studies of cancer risk and dichloromethane exposure. 
 Cancer type, 
    [reference]  Study Details  Exposure assessment  Results 
a 
Brain 
Heineman [41] 
Louisiana, New Jersey, Philadelphia; 300 cases, 
320 controls (death certificates); 1978–1981; 
cancer confirmed by hospital records; white men, 
participation rate 88% (cases), 83% (controls) 
Job exposure matrix applied to detailed 
information on all jobs held (at least 1 year) 
since age 15, as obtained from next-of-kin 
interviews; probability, duration, intensity, and 
cumulative exposure scores; six solvents 
evaluated 
OR 1.3 (0.9–1.8) for any exposure; 
increased risk with increased 
probability (trend p-value < 0.05, OR 
2.4 [1.0–5.9] for high probability), 
increased duration, increased intensity; 
strongest effects seen in high 
probability plus high duration, OR 6.1 
(1.1–43.8) or high intensity and high 
duration, OR 6.1 (1.5–28.3) 
combinations; no association with 
cumulative exposure score Int. J. Environ. Res. Public Health 2011, 8                 
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Table 3. Cont. 
Cancer type, 
[reference] 
 
Study Details 
 
Exposure assessment 
 
Results 
a 
Brain 
Cocco [40] 
24 states (United States); 12,980 cases, 
51,920 controls (death certificates); 1984–1992; 
women 
Job exposure matrix applied to death 
certificate occupation; probability, and 
intensity scores; 11 exposures evaluated 
Weak association overall, OR 1.2  
(1.1–1.3), no trend with probability or 
intensity scores 
Breast 
Cantor [36] 
24 states (United States); 33,509 cases, 
117,794 controls (death certificates); 1984–1989; 
black and white women 
Job exposure matrix applied to death 
certificate job data, probability, and exposure 
level; 31 substances evaluated 
Little evidence of association with 
exposure probability; weak association 
with highest exposure level in whites, 
OR 1.17 (1.1–1.3) and in blacks, 
OR 1.46 (1.2–1.7) 
Pancreatic 
Kernan [37] 
24 states (United States); 63,037 cases, 
252,386 controls (death certificates); 1984–1993; 
black and white men and women 
Job exposure matrix applied to death 
certificate occupation, probability, and 
intensity scores; 11 chlorinated solvents and 
formaldehyde evaluated 
Little evidence of associations with 
intensity or probability 
Kidney 
Dosemeci [38] 
Minnesota; 438 incident cases (Minnesota cancer 
registry), 687 controls (random digit dialing and 
Medicare records); 1988–1990; cancer confirmed 
by histology; men and women, participation rate 
87% (cases), 86% (controls) 
Job exposure matrices applied to most recent 
and usual job, as ascertained from interviews; 
nine solvents evaluated 
No evidence of increased risk 
associated with dichloromethane in 
men, OR 0.85 (0.6–1.2) or women, OR 
0.95 (0.4–2.2) 
Rectal 
Dumas [39] 
Montreal, Canada; 257 incident cases, 
1,295 other cancer controls from 19 hospitals; 
533 population-based controls (electoral rolls and 
random digit dialing), 1979–1985 cancer 
confirmed by histology; men, participation rate 
85% (cases), not reported (other cancer controls), 
72% (population-based controls) 
Job exposure matrix applied to detailed 
information on all jobs held, as ascertained 
from interviews; 294 substances evaluated 
Little evidence of an association with 
any exposure, OR 1.2 (0.5–2.8), but 
increased risk in a small, “substantial 
exposure” group, OR 3.8 (1.1–12.2) 
(using cancer controls; analysis of 
population controls not given for this 
exposure) Int. J. Environ. Res. Public Health 2011, 8                 
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4. Discussion 
Liver cancer has been a major focus of research on dichloromethane. No data from a case-control 
study of liver cancer are available pertaining to dichloromethane exposure. The cohort study with the 
higher exposures, the South Carolina triacetate fiber production plant, suggested an increased risk of 
liver cancer [28,31]. The SMR for liver and biliary tract cancer was 2.98 (95% CI 0.81–7.63) in the 
latest update of this cohort. This observation was based on four cases; three of these cases were biliary 
tract cancers, a very rare form of cancer (expected number estimated as 0.15 cases in [28]). No other 
cohort study has reported an increased risk of liver cancer mortality, although it should be noted that 
there is no other inception cohort study of a population with exposure levels similar to those of the 
South Carolina plant.  
In the 2-year NTP inhalation exposure study in B6C3F1 mice (exposure concentrations 0, 2,000, 
and 4,000 ppm), the liver tumor incidence in male mice increased from 44% in controls to 66% at 
4,000 ppm; in females, the incidence rose from 6% to 83% across dose groups (both mortality-adjusted 
trend p-values < 0.001) [3,4]. The results of an oral exposure (drinking water) study in B6C3F1 mice 
are more ambiguous, however [45,46]. There was no indication of an increased incidence of liver 
tumors in female mice in this study. In males, the incidence of hepatocellular adenomas or carcinomas 
was 18% and 20% in each of two control groups (combined incidence, 19%), increasing to 26%, 30%, 
31%, and 28% in the 60, 125, 185 and 250 mg/kg-day groups, respectively. Serota et al. concluded that 
there  was  no  dose-related  trend  and  that  there  were  no  significant  pair-wise  differences  with  the 
controls, but other interpretations are also supported by the results [46]. Although not provided by 
Serota  et  al.  [46],  the  statistical  results  are  presented  in  the  full  report  of  the  study  (Hazleton 
Laboratories,  [45]):  the  trend  p-value  was  0.058;  p-values  for  the  pair-wise  comparisons  with  the 
combined control group were p = 0.071, 0.023, 0.019, and 0.036 for the 50, 125, 185, and 250 mg/kg 
per day dose groups, respectively. None of the chronic exposure studies in rats have shown a relation 
between dichloromethane exposure and liver or lung tumors [3,45,47-49].  
The  relevance  of  the  bioassay  studies  of  dichloromethane  in  mice  to  humans  in  low-exposure 
scenarios has been questioned, given the high exposure conditions of the genotoxicity studies and 
animal bioassays, the high background rates of liver cancer in male B6C3F1 mice, and the relatively 
high GST activity in mice [50]. Comparisons in mice, rats, and humans of GST enzyme activity in 
liver and lung tissues indicate a much higher activity in mice. In liver tissue samples, mean GST-T1 
activity was 29.7, 18.2, 3.70, 1.60 nmol/min per mg protein in female mice, male mice, rats, and 
human  GST-high  conjugator  groups,  respectively  [51].  Another  potentially  relevant  interspecies 
difference is the localization of GST-T1 within cells. In the mouse, localization is seen in the nuclei of 
hepatocytes and bile-duct epithelium, while the rat liver does not show preferential nuclear localization 
of GST-T1. In human liver tissue, some hepatocytes show nuclear localization of GST-T1 and others 
show localization in cytoplasm, as well as in nuclei of bile duct epithelial cells [52,53].  
Consideration of metabolic polymorphisms, both in CYP and GST pathways, however, is important 
and may modulate susceptibility, as has been shown for trichloroethylene [54]. GST-T1 is expressed at 
a variety of sites in addition to the liver and lung, including mammary tissue [55], brain [56], and 
peripheral lymphoctyes [8]. The extent of GSH conjugation and presence of polymorphic phenotypes Int. J. Environ. Res. Public Health 2011, 8                 
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in  these  tissues  may  be  significant  in  understanding  the  sites  of  action  of  dichloromethane,  and 
potential differences in site concordance between species. 
The  cohort  studies  pertaining  to  brain  cancer  risk are  statistically  underpowered  given  the  few 
observed cases, 1 to 6 deaths, and their variable findings are not surprising. The Heineman et al. study, 
the stronger of the two brain cancer case-control studies in terms of exposure assessment strategy and 
confirmation  of  diagnosis,  reported  relatively  strong  trends  (p  <  0.05)  wih  increasing  probability, 
duration,  and  intensity  measures  of  exposure,  and  with  the  combination  of  high  intensity  (or 
probability) and long (>20 years) duration of exposure (OR 6.1, 95% CI 1.5–28.3) [41]. These strong 
trends  were  not  seen  with  the  cumulative  exposure  metric.  The  difference  in  patterns  seen  with 
cumulative  compared  to  other  exposure  metrics  may  reflect  a  more  valid  measure  of  relevant 
exposures  in  the  brain  from  the  intensity  measure,  as  suggested  by  the  study  in  rats  reported  by 
Savolainen  et  al.  in  which  dichloromethane  levels  in  the  brain  were  much  higher  with  a  higher 
intensity  exposure  scenario  compared  with  a  constant  exposure  period  with  an  equivalent  
time-weighted average [57]. A statistically significant increased incidence of brain or central nervous 
system tumors has not been observed in any of the animal cancer bioassays, but a 2-year study using 
relatively low exposure levels (0, 50, 200, and 500 ppm) in Sprague-Dawley rats observed a total of 
six astrocytoma or glioma (mixed glial cell) tumors in the exposed groups (in females, the incidence 
was 0, 0, 0, and 2 in the 0, 50, 200, and 500 ppm exposure groups, respectively; in males, the incidence 
was 0, 1, 2, and 1 in the 0, 50, 200, and 500 ppm exposure groups, respectively; sample size of each 
group was 70 rats) [49]. These tumors are exceedingly rare in rats, and there are few examples of 
statistically significant trends in animal bioassays [58].  
Large  population-based  case-control  studies  of  incident  non-Hodgkin  lymphoma  or  multiple 
myeloma in Germany [18], Italy [17] and the United States [19,20,22] observed ORs between 1.5 and 
2.2 with dichloromethane exposure (ever exposed, or highest category of exposure), with higher risk 
among specific subsets of disease. An extensive exposure assessment protocol was used in several of 
these studies [17,18,22], including job-specific and industry-specific questionnaire modules focusing 
on potential exposure to specific solvents. Thus although the available epidemiologic studies do not 
definitively establish an increased cancer risk in relation to dichloromethane exposure, the consistent 
observations of associations with non-Hodgkin lymphoma indicate that this type of effect is a concern 
that cannot be dismissed based on available data. Additional studies focusing on specific subtypes of 
hematopoietic  cancers,  particularly  non-Hodgkin  lymphoma,  and  multiple  myeloma,  are  needed. 
Childhood  leukemia  differs  from  adult-onset  hematopoietic  cancers  with  respect  to  etiologically 
relevant  time  window  of  exposure  and  potential  biological  mechanisms  [59].  Only  one  study  of 
childhood leukemia and dichloromethane is available [21]. The results from this study also indicate 
that further research into this issue is warranted, and would build upon previous research of childhood 
leukemia and the broader category of parental (paternal or maternal) solvent exposure [60]. 
Important to any examination of a collection of epidemiology studies are the changes in diagnostic 
and  classification  criteria  of  human  lymphoid  tumors,  particularly  non-Hodgkin  lymphoma,  where 
classification changes are most significant [61]. A major shift in thinking occurred around 1995 with 
the Revised European-American Lymphoma (REAL) classification of grouping diseases of the blood 
and lymphatic tissues along their cell lines compared to previous approaches grouping lymphomas by 
a cell’s physical characteristics. It was increasingly recognized that some non-Hodgkin lymphomas Int. J. Environ. Res. Public Health 2011, 8                 
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and  corresponding  lymphoid  leukemias  were  different  phases  (solid  and  circulating)  of  the  same 
disease  entity  [62].  Diagnostic  and  classification  criteria  may  not  be  uniform  across  studies. 
Classification differences hinder comparison of consistency across epidemiologic studies of lymphoid 
cancers and dichloromethane. In addition, the misclassification of disease subtype would be expected 
to result in attenuated effect estimates, as it is unlikely to be systematically related to exposure. The 
cohort studies conducted in the 1990s used ICD-9 or ICD-8 classifications, which do not incorporate 
some of the concepts of contemporary knowledge of lymphomas that have been used in more recent 
case-control studies.  
Based on this review, a number of suggestions for future epidemiology  research  can be made. 
Existing cohort studies, given their size and uneven exposure information, are unlikely to  resolve 
questions of cancer risks and dichloromethane exposure; however, further follow-up in the New York 
film cohort [29] may provide limited additional information. Given the low incidence of brain, liver 
and hematological cancers, and the small number of women in these cohorts, more promising are  
case-control studies of incident cases identified from population-based cancer registries, such as the 
National  Cancer  Institute’s  SEER  registry.  Case-control  studies  should  include  robust  exposure 
assessments such as those used in the study of Gold et al. [22] with detailed occupational information 
and exposure assignment referencing industry-wide surveys (see Bakke et al. [63] and Gold et al. [64] 
for descriptions of assessments of trichloroethylene and tetrachloroethylene, respectively), or methods 
that incorporate exposure measures in selected scenarios with questionnaire-based information [65]. 
Review of task-level information and supplemental questionnaire modules, in addition to industry and 
occupation  codes,  as  was  done  in  the  more  recent  studies  of  hematological  cancers,  can  provide 
valuable information that can improve the sensitivity and specificity of an exposure assessment used in 
case-control studies [66].  
It may also be possible to combine data from the case-control studies of hematological cancers we 
identified,  given  the  similarities  in  the  exposure assessment  methodologies  used  in  the  studies,  to 
provide  more  robust  estimates  of  effects  in  specific  subtypes  of  these  cancers,  effects  based  on 
different exposure metrics, and effects adjusting for other exposures. The large sample size produced 
by such an aggregation of studies would be needed to examine gene-environment interactions. For 
dichloromethane, it is the GST-T1 metabolic pathway that is thought to result in genotoxicity and 
carcinogenicity. Thus higher risk would be expected among individuals with the GST-T1
+/+ genotype 
compared with the GST-T1
-/- (null) genotype. Effect modification (i.e., higher risk) would also be 
expected with genetic variants, or with co-exposures with other CYP substrates (e.g., alcohol, some 
other  solvents),  that  result  in  lower  CYP2E1  activity  and  thus  higher  GST-T1  metabolism  of 
dichloromethane.  Barry  et  al.  reported  an  interaction  between  the  TT  genotype  of  CYP2E1 
rs20760673,  dichloromethane  exposure,  and  risk  of  non-Hodgkin  lymphoma  (OR  4.42,  95%  CI  
2.03–9.62) [19], but the functional significance of the variant is not known. 
The available data from the large cohort of civilian workers at an Air Force base indicate that a 
number of solvents, including dichloromethane, may be associated with breast cancer risk [33]. Future 
studies examining this issue should enable control of reproductive risk factors, through the choice of 
referent  group  or  adjustment  in  the  analysis.  Potential  confounding  by  co-exposures  (e.g.,  other 
solvents) should also be addressed in breast cancer studies.  Int. J. Environ. Res. Public Health 2011, 8                 
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In  summary,  developments  in  exposure  assessment  for  use  in  population  settings,  disease 
classification, and the creation of large-scale cohorts of people at higher risk for some diseases, such as 
the  Sister  Study  for  breast  cancer  [67],  provide  a  strong  foundation  for  future  epidemiological  
studies  of  dichloromethane  and  other  solvents.  The  insights  generated  from  these  studies  can  
contribute  greatly  to  our  understanding  of  disease  risk,  and  to  the  interpretation  of  animal  and  
mechanistic studies.  
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